Search research articles
Contact Us
Filters
Showing results (161-170 of 471) with videos related to
Page
of 48
Sort By:
Archives of Internal Medicine
|
August 13, 2008
The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program
Hertzel C Gerstein, Karl Swedberg, Jonas Carlsson, et al.
Plos One
|
September 1, 2018
Effects of a person-centred telephone-support in patients with chronic obstructive pulmonary disease and/or chronic heart failure - A randomized controlled trial
Andreas Fors, Elin Blanck, Lilas Ali, et al.
The American Journal of Cardiology
|
November 26, 2003
Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome
J Robert Swenson, Christopher M O'Connor, David Barton, et al.
European Journal of Heart Failure
|
April 15, 2010
Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF)
Faiez Zannad, John J V McMurray, Helmut Drexler, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
May 12, 2012
Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study
Michael Böhm, Jeffrey Borer, Ian Ford, et al.
ESC Heart Failure
|
October 9, 2019
Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m
Nadia Bouabdallaoui, Eileen O'Meara, Virginie Bernier, et al.
European Journal of Heart Failure
|
February 8, 2014
The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT
Adriaan A Voors, Dirk J van Veldhuisen, Michele Robertson, et al.
European Journal of Heart Failure
|
March 6, 2013
Risk following hospitalization in stable chronic systolic heart failure
Putte Abrahamsson, Karl Swedberg, Jeffrey S Borer, et al.
The Canadian Journal of Cardiology
|
June 23, 2015
Pharmacologic Options for the Management of Systolic Heart Failure: Examining Underlying Mechanisms
G B John Mancini, Jonathan G Howlett, Jeffrey Borer, et al.
European Heart Journal
|
August 29, 2012
Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study
Jeffrey S Borer, Michael Böhm, Ian Ford, et al.
Page
of 48
Search research articles
Search
Showing results (161-170 of 471) with videos related to
Sort By:
Page
of 48
Archives of Internal Medicine
|
August 13, 2008
The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program
Hertzel C Gerstein, Karl Swedberg, Jonas Carlsson, et al.
Plos One
|
September 1, 2018
Effects of a person-centred telephone-support in patients with chronic obstructive pulmonary disease and/or chronic heart failure - A randomized controlled trial
Andreas Fors, Elin Blanck, Lilas Ali, et al.
The American Journal of Cardiology
|
November 26, 2003
Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome
J Robert Swenson, Christopher M O'Connor, David Barton, et al.
European Journal of Heart Failure
|
April 15, 2010
Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF)
Faiez Zannad, John J V McMurray, Helmut Drexler, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
May 12, 2012
Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study
Michael Böhm, Jeffrey Borer, Ian Ford, et al.
ESC Heart Failure
|
October 9, 2019
Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m
Nadia Bouabdallaoui, Eileen O'Meara, Virginie Bernier, et al.
European Journal of Heart Failure
|
February 8, 2014
The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT
Adriaan A Voors, Dirk J van Veldhuisen, Michele Robertson, et al.
European Journal of Heart Failure
|
March 6, 2013
Risk following hospitalization in stable chronic systolic heart failure
Putte Abrahamsson, Karl Swedberg, Jeffrey S Borer, et al.
The Canadian Journal of Cardiology
|
June 23, 2015
Pharmacologic Options for the Management of Systolic Heart Failure: Examining Underlying Mechanisms
G B John Mancini, Jonathan G Howlett, Jeffrey Borer, et al.
European Heart Journal
|
August 29, 2012
Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study
Jeffrey S Borer, Michael Böhm, Ian Ford, et al.
Page
of 48